Close

 

Fund Holdings (%)1,2 as of Jan 31, 2024

Holding % of Net Assets
Eli Lilly & Co 8.59%
UnitedHealth Group Inc 7.34%
Novo Nordisk A/S 6.46%
AbbVie Inc 5.20%
Thermo Fisher Scientific Inc 4.96%
AstraZeneca PLC 4.66%
Roche Holding AG 4.04%
Intuitive Surgical Inc 3.87%
Danaher Corp 3.86%
Johnson & Johnson 3.58%
Sanofi 3.46%
Boston Scientific Corp 3.42%
Stryker Corp 3.29%
Zoetis Inc 3.25%
Vertex Pharmaceuticals Inc 2.77%
Merck & Co Inc 2.46%
Bristol-Myers Squibb Co 2.26%
CSL Ltd 2.26%
McKesson Corp 2.01%
Alcon Inc 1.91%
Cooper Cos Inc 1.91%
Neurocrine Biosciences Inc 1.88%
Zimmer Biomet Holdings Inc 1.85%
SPDR S&P Biotech ETF 1.70%
Centene Corp 1.24%
Lonza Group AG 1.11%
Humana Inc 1.02%
Pfizer Inc 0.97%
Royalty Pharma PLC 0.91%
Teleflex Inc 0.89%
ARGENX SE - ADR 0.84%
Amplifon SpA 0.80%
Sartorius AG 0.80%
Align Technology Inc 0.76%
Straumann Holding AG 0.74%
Neogen Corp 0.65%
AptarGroup Inc 0.58%
Agiliti Inc 0.50%
Asahi Intecc Co Ltd 0.49%
MSILF GOVERNMENT PORTFOLIO MSILF GOVERNMENT PORTFOLIO 0.33%
JMDC Inc 0.22%
CARIS LIFE SCIENCES, INC 0.05%